Stock listing

TPEx:6986 HeXun Biosciences Co Ltd (和迅) 股價

Follow HeXun Biosciences Co Ltd into a list and get an email when it puts out news.

Share price · TPEX:6986

$36.90 TWD -2.80 (-7.1%)

Close on Nov 20, 2026

Past year -31.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$35.10 – $37.10 TWDNov 20, 2026
Volume
60,065 sharesNov 20, 2026
Market cap
$1.89B TWDAt the close on Nov 20, 2026 · price × 51.09M shares outstanding
52-week range
$35.10 – $71.60 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.81M TWDMedian day 54,085 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
HeXun Biosciences Co Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6986 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$36.90-2.80-7.1%$36.40$37.10$35.1060,065
$39.70-0.35-0.9%$40.15$40.15$37.2529,025
$40.05+0.55+1.4%$40.45$40.45$37.4048,001
$39.50-0.50-1.3%$40.00$40.00$37.8511,068
$40.00+2.50+6.7%$37.50$41.20$37.1094,000
$37.500.000.0%$39.15$39.20$36.8063,012
$37.50+0.20+0.5%$36.55$37.50$35.6055,169
$37.30-1.70-4.4%$39.10$39.85$36.25178,979
$39.00-1.10-2.7%$40.10$40.10$39.0027,207
$40.10-2.35-5.5%$39.50$40.15$39.5081,270
$42.45-0.55-1.3%$43.05$43.15$41.8072,154
$43.00-0.15-0.3%$43.50$43.50$42.9059,075
$43.15-0.15-0.3%$43.20$43.90$42.8599,120
$43.300.000.0%$43.30$43.50$43.3029,047
$43.30-0.30-0.7%$43.80$43.80$43.3040,300
$43.60-0.15-0.3%$43.75$43.75$43.6014,000
$43.75+0.05+0.1%$43.75$43.75$43.7015,055
$43.70-0.10-0.2%$43.85$43.85$43.7012,000
$43.800.000.0%$43.80$43.80$43.800
$43.80-0.85-1.9%$42.80$44.65$42.8052,647
$44.65+0.25+0.6%$44.55$45.00$44.4044,012
$44.40-0.10-0.2%$44.70$44.70$44.3510,019
$44.50-0.25-0.6%$44.75$44.75$44.4544,615
$44.75+0.75+1.7%$44.15$44.80$44.0574,000
$44.00-0.15-0.3%$44.15$44.20$44.0073,000
$44.15+0.10+0.2%$44.05$44.35$44.0520,000
$44.050.000.0%$44.00$44.15$43.9076,000
$44.05-0.25-0.6%$44.40$44.40$43.9546,000
$44.30+0.10+0.2%$44.00$44.30$44.0035,000
$44.20+0.20+0.5%$43.80$44.45$43.8053,000
$44.000.000.0%$44.00$44.00$43.90146,000
$44.000.000.0%$43.90$44.00$43.0586,017
$44.000.000.0%$44.10$44.10$43.90213,000
$44.00-0.05-0.1%$44.90$44.90$43.90180,000
$44.05+0.05+0.1%$44.05$44.25$44.00148,000
$44.00-0.30-0.7%$44.30$44.30$42.8067,000
$44.30-1.20-2.6%$45.90$45.90$44.0044,000
$45.50+0.25+0.6%$45.25$45.90$44.80127,000
$45.25+1.05+2.4%$42.60$46.40$41.50160,000
$44.20+4.00+10.0%$40.80$44.20$40.30217,000
$40.20-0.20-0.5%$40.50$40.50$39.40104,010
$40.40-0.10-0.2%$40.25$40.40$40.2037,000
$40.50+0.25+0.6%$40.30$40.50$40.0544,000
$40.25-0.10-0.2%$40.10$40.50$40.1021,000
$40.35-0.10-0.2%$41.00$41.20$40.0038,000
$40.45-0.20-0.5%$40.35$40.60$40.1059,000
$40.65-0.10-0.2%$40.65$42.20$40.6048,005
$40.75-0.55-1.3%$41.00$41.00$40.0565,000
$41.30-0.20-0.5%$40.85$41.30$40.75107,000
$41.50-0.30-0.7%$41.60$41.60$40.8063,035
$41.80+0.30+0.7%$41.95$42.20$40.1064,000
$41.50-1.00-2.4%$42.20$42.65$40.5045,000
$42.50-0.40-0.9%$42.80$42.95$42.0537,000
$42.900.000.0%$43.90$43.90$42.3553,000
$42.90+1.30+3.1%$40.80$43.50$40.8065,000
$41.60-0.10-0.2%$41.05$41.70$40.0576,000
$41.70-0.05-0.1%$41.85$41.90$41.7045,000
$41.75-0.55-1.3%$41.90$42.30$41.6531,034
$42.30-0.50-1.2%$42.80$42.80$40.7059,000
$42.80-0.20-0.5%$42.90$43.00$42.5031,000
$43.00-0.10-0.2%$43.30$43.35$42.8040,000
$43.10+0.20+0.5%$43.20$43.20$42.4559,000
Ticker
TPEx:6986
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

HeXun Biosciences Co Ltd on 6ix

Sector
Health care
Industry
Biotechnology
Decks
3 decks · latest Jul 16, 2026

Valuation

EV/sales 3.4× against a median of 8.5×: 2nd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.06B TWD
P/E
16.2×
EV/sales
3.4×
EV/EBITDA
6.5×
Price/book
1.8×
Gross margin
91.0%
Operating margin
42.4%
Net margin
37.7%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
HeXun Biosciences Co Ltd · TPEX:6986US$57.20MUS$32.05M16.2×3.4×6.5×1.8×37.7%0.0×n/a
Rani Therapeutics Holdings, Inc. · NASDAQ:RANIUS$58.99MUS$16.85Mn/a2.6×n/a1.7×−493.0%0.1×2.21
iNtRON Biotechnology, Inc. · KRX:048530US$57.05MUS$31.20Mn/a5.8×n/a1.2×−142.6%0.0×n/a
Tenax Therapeutics, Inc. · NASDAQ:TENXUS$56.92M−US$56.78Mn/an/an/a0.5×n/a0.0×1.35
Kazia Therapeutics Ltd · NASDAQ:KZIAUS$56.22MUS$10.34Mn/a372×n/a1.8×n/a0.0×2.31
OKYO Pharma Limited · NASDAQ:OKYOUS$56.15MUS$35.56Mn/an/an/a4.5×n/a0.0×1.02
Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704US$55.78MUS$51.66Mn/a9.1×n/a2.5×−43.0%0.3×n/a
Cognition Therapeutics, Inc. · NASDAQ:CGTXUS$55.37MUS$25.10Mn/an/an/a1.9×n/a0.0×2.28
EyeGene, Inc. · KRX:185490US$55.25MUS$26.51Mn/a8.0×n/a1.5×−391.5%0.0×n/a
AB Science SA · EURONEXT:ABUS$55.18MUS$50.52Mn/a39.2×n/an/a−132.6%n/an/a
Azora Therapeutics, Inc. · NASDAQ:AZRUS$55.00MUS$33.00Mn/an/an/an/an/an/a1.00
Median of the othersUS$55.97MUS$28.85M8.5×1.8×−142.6%0.0×1.78

Decks

DeckKindSlidesDate
和迅生技產業論壇 2026Conference43 slidesJul 16, 2026
Investor Presentation (May 2026)Investor deck53 slidesMay 29, 2026
Investor Presentation (August 2024)Investor deck54 slidesAug 2, 2024

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue293.2M286.4M130.6M49.5M0
Cost of revenue26.9M25.7M16.8M4.86M0
Gross profit266.3M260.7M113.7M44.6M0
Research and development99.2M65.4M53.2M39.4M44.7M
Selling, general and administrative49.1M35.4M29.6M13.5M5.95M
Operating income118.0M155.7M27.4M-3.55M-50.7M
Depreciation and amortization28.9M24.7M20.3M14.7M11.9M
EBITDA146.9M180.4M47.7M11.2M-38.8M
Interest expense1.11M1.18M1.85M1.64M1.57M
Income before tax125.9M161.5M33.5M-5.19M-43.0M
Income tax14.2M
Net income111.9M147.2M33.5M-5.19M-43.0M
Earnings per share, basic2.433.200.89-0.14-1.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents208.2M201.0M257.7M119.7M85.0M71.7M
Short-term investments301.4M172.0M72.0M72.0M
Receivables74.2M84.7M22.3M4.98M0
Inventory6.02M15.6M4.60M0
Current assets609.6M483.2M363.7M211.2M93.4M78.7M
Total assets837.1M706.9M571.4M404.2M294.6M266.2M
Accounts payable3.17M4.24M4.98M5.44M3.40M2.55M
Current liabilities62.5M53.8M30.2M20.0M7.83M11.8M
Long-term debt034.9M37.3M39.4M
Total debt35.0M70.1M69.4M74.1M80.9M
Total liabilities95.5M86.3M98.1M89.3M79.9M86.5M
Shareholders' equity741.6M620.6M473.4M314.9M214.8M179.7M
Shares outstanding46.0M46.0M37.5M37.5M30.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations163.9M120.9M43.1M11.2M-35.5M
Capital spending-28.9M-37.3M-22.8M-1.23M0
Free cash flow135.0M83.6M20.3M10.0M-35.5M
Cash from investing-137.3M-25.3M-79.0M-26.9M
Cash from financing-40.3M120.1M102.5M75.8M
Change in cash7.21M-56.7M137.9M34.7M13.3M

Open Financials

Cap table

Built by 6ix from HeXun Biosciences Co Ltd’s releases

Common shares
51,090,000
Fully diluted
51,090,000

Fully diluted

LineShares
Common shares51,090,000

Share count over time

CountShares
Nov 22, 202651,090,000

Open Cap table

Shareholders

HolderSharesOf the companyChangeAs of
温政翰4.08M7.8%No changeOct 31, 2026
黃濟鴻2.45M4.7%No changeOct 31, 2026
易德投資股份有限公司1.57M3.0%No changeOct 31, 2026
陳松遠150K0.29%No changeOct 31, 2026
福豐盛投資股份有限公司100K0.19%No changeOct 31, 2026
陳婉昕75,0000.14%No changeOct 31, 2026
藍御慎53,0000.10%No changeOct 31, 2026
林嘉勲00.00%NewOct 31, 2026
陳鴻文00.00%NewOct 31, 2026
陳韋村00.00%NewOct 31, 2026
All 16 holders
HolderSharesOf the companyChangeAs of
陳明賢00.00%NewOct 31, 2026
朱建成00.00%NewOct 31, 2026
魏宗德00.00%NewOct 31, 2026
林柏儒00.00%NewOct 31, 2026
蔡采薇00.00%NewOct 31, 2026
江錫仁00.00%NewOct 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about HeXun Biosciences Co Ltd.